Supernus Pharmaceuticals | SUPN - Pre Tax Profit


Supernus Pharmaceuticals reported $-1.91M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.36B 178M Dec/2025
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Aurora Cannabis CAD -1.58M 48.55M Dec/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Canopy Growth CAD -62.26M 60.84M Dec/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Eisai JPY 22B 7.47B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Pacira USD 9.52M 11.45M Sep/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Supernus Pharmaceuticals USD -1.91M 56.04M Dec/2025
United Therapeutics USD 444M 6M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025